Circulating miR-130 is a potential bio signature for early prognosis of acute myocardial infarction.

Conclusions: These results indicate that circulating miR-130 holds great promise as an effective biomarker for diagnosing AMI earlier. PMID: 33447421 [PubMed]

https://www.ncbi.nlm.nih.gov/pubmed/33447421?dopt=Abstract

Source: Journal of Thoracic Disease - January 17, 2021 Category: Respiratory Medicine Tags: J Thorac Dis Source Type: research

More News: Electrocardiogram | Heart Attack | Respiratory Medicine | Study